Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$20.3M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 34 most recent Form 4 transactions.
| — |
| — |
| Open the original filing on SEC.gov |
| Mar 12 | XENE | Xenon Pharmaceuticals Inc. | MEXER◷ | 12,500 | — | — | +84.9% | Open the original filing on SEC.gov |
| Mar 10 | XENE | Xenon Pharmaceuticals Inc. | SSELL◷ | 11,269 | $60.11 | $677.4K | -43.3% | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | MEXER◷◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | AGRANT◷◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | MEXER◷◆ | 65,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | MEXER◷◆ | 105,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | MEXER◷◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | MEXER◷◆ | 75,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | MEXER◷ | 20,000 | — | — | +333.3% | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | SSELL◷ | 65,000 | $62.06 | $4M | -91.5% | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | MEXER◷ | 65,000 | $9.44 | $613.6K | +1,083% | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | SSELL◷ | 61,652 | $60.08 | $3.7M | -91.1% | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | SSELL◷ | 43,348 | $59.26 | $2.6M | -37.4% | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | MEXER◷ | 105,000 | $4.75 | $498.8K | +1,750% | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | SSELL◷ | 2,449 | $61.26 | $150K | -29.0% | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | SSELL◷ | 10,072 | $60.47 | $609.1K | -54.4% | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | SSELL◷ | 12,479 | $59.50 | $742.5K | -40.3% | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | MEXER◷ | 25,000 | $3.10 | $77.5K | +416.7% | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | SSELL◷ | 21,515 | $60.49 | $1.3M | -78.2% | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | SSELL◷ | 31,694 | $59.88 | $1.9M | -53.5% | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | SSELL◷ | 21,791 | $58.81 | $1.3M | -26.9% | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | MEXER◷ | 75,000 | $8.40 | $630K | +1,250% | Open the original filing on SEC.gov |
| Jan 9 | XENE | Xenon Pharmaceuticals Inc. | AGRANT◆ | 65,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 9 | XENE | Xenon Pharmaceuticals Inc. | AGRANT◆ | 350,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | XENE | Xenon Pharmaceuticals Inc. | MEXER◷◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | XENE | Xenon Pharmaceuticals Inc. | SSELL◷ | 2,062 | $44.93 | $92.6K | -25.6% | Open the original filing on SEC.gov |
| Jan 2 | XENE | Xenon Pharmaceuticals Inc. | SSELL◷ | 37,938 | $44.40 | $1.7M | -82.5% | Open the original filing on SEC.gov |
| Jan 2 | XENE | Xenon Pharmaceuticals Inc. | MEXER◷ | 40,000 | $7.49 | $299.6K | +666.7% | Open the original filing on SEC.gov |
| Dec 8, 2025 | XENE | Xenon Pharmaceuticals Inc. | SSELL◷ | 2,010 | $46.32 | $93.1K | -25.1% | Open the original filing on SEC.gov |
| Dec 8, 2025 | XENE | Xenon Pharmaceuticals Inc. | SSELL◷ | 8,820 | $45.59 | $402.1K | -52.4% | Open the original filing on SEC.gov |
| Dec 5, 2025 | XENE | Xenon Pharmaceuticals Inc. | SSELL◷ | 14,375 | $45.03 | $647.3K | -46.1% | Open the original filing on SEC.gov |
| Nov 28, 2025 | XENE | Xenon Pharmaceuticals Inc. | SSELL◷ | 97 | $45.01 | $4.4K | -0.3% | Open the original filing on SEC.gov |